The results obtained here with paclitaxel are supported by earlier in vivo investigations that have shown that the taxane is ineffective at inhibiting the growth of breast carcinoma tumours that overexpress P-glycoprotein (Newman et al, 2000; Loganzo et al, 2003). The gene discussed is ABCB1; the disease is breast carcinoma.